Summary & Overview
HCPCS Level II J0200: Injection, alatrofloxacin mesylate, 100 mg
HCPCS Level II code J0200 denotes a 100 mg injection of alatrofloxacin mesylate, an intravenous antibiotic preparation. As a drug-specific HCPCS Level II code, J0200 is used on medical claims to identify the administered pharmaceutical product separate from procedure or facility charges. Nationally, accurate use of such HCPCS drug codes matters for drug utilization tracking, payment adjudication, and antimicrobial stewardship reporting.
Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for an intravenous antibiotic product, common sites of service where billing occurs, and the payer landscape covered in the analysis. The publication provides benchmarks for coding and reimbursement patterns, notes on billing considerations for HCPCS drug codes, and context on how this code integrates with service lines that manage acute infections.
This summary equips billing managers, revenue cycle staff, and policy analysts with the core facts needed to locate J0200 in claims workflows, understand which payers are commonly involved, and identify areas where further payer-specific policy detail may be required.
Billing Code Overview
HCPCS Level II code J0200 represents Injection, alatrofloxacin mesylate, 100 mg. This code is used to bill for the administration of the specified intravenous antibiotic preparation.
-
Service type: Intravenous antibiotic injection
-
Typical site of service: Hospital inpatient, hospital outpatient, emergency department, or other acute care settings where intravenous antibiotics are administered
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an outpatient infusion center or hospital inpatient ward with a serious gram-negative bacterial infection such as complicated intra-abdominal infection, complicated urinary tract infection, or hospital-acquired/ventilator-associated pneumonia where an intravenous fluoroquinolone antibiotic is indicated. The medication J0200 (injection, alatrofloxacin mesylate, 100 mg) is administered by a licensed nurse or pharmacist via IV infusion after order verification. Workflow steps include clinical assessment and indication confirmation, allergy and medication reconciliation, order entry with dose calculations, preparation of the vial in pharmacy under aseptic technique, administration via peripheral IV or central line, monitoring for infusion-related adverse reactions (including anaphylaxis, QT prolongation, tendonitis), documentation of lot number and amount administered, and billing using the HCPCS level II code J0200 with appropriate modifier when required. Typical sites of service are outpatient infusion centers, emergency departments, observation units, and inpatient hospital floors where parenteral antibiotic therapy is delivered.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when administration requires substantially greater resources or complexity than usual (document rationale). |